Education
About Us
Working with TipRanks
Follow Us
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
See the Price Targets and Ratings of:
XVIPF Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Danske Bank
$57.85→$33.58
Sell
67.79%
Upside
Downgraded
03/25/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Danske Bank
$57.85→$33.58
Sell
67.79%
Upside
Downgraded
03/25/25
Best Analysts Covering Xvivo Perfusion AB
1 Month
xxx
Success Rate
1/1 ratings generated profit
Average Return
+6.40%
downgraded a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+11.40%
downgraded a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +11.40% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+39.60%
downgraded a sell rating 5 months ago
Copying Erik Cassel's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +39.60% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+39.60%
downgraded a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +39.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XVIPF Analyst Recommendation Trends
Rating
Jul 24
Mar 25
Apr 25
Jun 25
Jul 25
Strong Buy
1
2
1
2
1
Buy
0
0
0
0
0
Hold
1
1
2
4
7
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
2
4
4
7
8
Each month's total comprises the sum of three months' worth of ratings.
XVIPF Stock Forecast FAQ
What is XVIPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Xvivo Perfusion AB’s 12-month average price target is 33.89.
What is XVIPF’s upside potential, based on the analysts’ average price target?
Xvivo Perfusion AB has 69.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is XVIPF a Buy, Sell or Hold?
Xvivo Perfusion AB has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Xvivo Perfusion AB’s price target?
The average price target for Xvivo Perfusion AB is 33.89. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $33.89 ,the lowest forecast is $33.89. The average price target represents 69.37% Increase from the current price of $20.01.
The highest analyst price target is $33.89 ,the lowest forecast is $33.89. The average price target represents 69.37% Increase from the current price of $20.01.
What do analysts say about Xvivo Perfusion AB?
Xvivo Perfusion AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of XVIPF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.